Valuation : Jerusalem Pharmaceutical Co.

Market Cap 128M 128M 110M 103M 94.31M 177M 12.16B 178M 1.22B 476M 6.17B 480M 469M 20.42B P/E 2024
13.7x
P/E 2025 8.13x
Enterprise Value 117M 117M 101M 94.51M 86.27M 162M 11.12B 163M 1.12B 436M 5.64B 439M 429M 18.68B EV / Sales 2024
1.47x
EV / Sales 2025 1.47x
Free-Float
35.74%
Yield 2024
2.09%
Yield 2025 3.26%
Manager TitleAgeSince
Chief Executive Officer - 2013-06-30
Director of Finance/CFO - 2020-02-29
Chief Tech/Sci/R&D Officer - 1988-12-31
Director TitleAgeSince
Chairman 91 -
Director/Board Member - -
Director/Board Member - -
Change 5-day change 1-year change 3-year change Capi.($)
-2.45%+1.47%+23.97%+74.35% 50.05B
+1.59%+1.97%+56.92%+124.49% 40.29B
-0.80%+4.53%+16.42%+84.36% 12.17B
+0.06%-1.79%-11.03%+12.29% 11.96B
+0.19%-.--%+29.35%+150.00% 9.25B
-1.80%-1.50%+25.41%+48.78% 7.62B
-0.15%+3.78%+28.77%+223.54% 7.36B
+1.47%+1.72%+45.98%-9.98% 7.21B
-0.84%-2.36%-36.62%+16.04% 5.26B
Average -0.24%+2.12%+19.91%+80.43% 16.8B
Weighted average by Cap. -0.42%+1.34%+28.95%+88.16%

Financials

2024 2025
Net sales 39.82M 39.82M 34.29M 32.19M 29.39M 55.21M 3.79B 55.6M 381M 148M 1.92B 150M 146M 6.36B 48.95M 48.95M 42.14M 39.57M 36.12M 67.86M 4.66B 68.34M 469M 182M 2.36B 184M 180M 7.82B
Net income 5.04M 5.04M 4.34M 4.07M 3.72M 6.98M 479M 7.03M 48.26M 18.78M 243M 18.92M 18.5M 805M 10.18M 10.18M 8.77M 8.23M 7.51M 14.12M 969M 14.22M 97.55M 37.96M 491M 38.23M 37.4M 1.63B
Net Debt -10.32M -10.32M -8.89M -8.34M -7.62M -14.31M -982M -14.41M -98.88M -38.47M -498M -38.76M -37.91M -1.65B -10.9M -10.9M -9.38M -8.81M -8.04M -15.11M -1.04B -15.22M -104M -40.62M -526M -40.91M -40.02M -1.74B
Logo Jerusalem Pharmaceutical Co.
Jerusalem Pharmaceuticals Co Ltd (Al-Quds) is a Palestine-based public shareholding company engaged in the manufacture and trade of pharmaceutical, veterinary, detergent, and cosmetics products. Its product range spans the whole spectrum of ethical pharmaceuticals, as well as over the counter preparations and nutritional supplements. Its Products are presented in different dosage forms such as tablets, capsules, ampoules, granules and powders for suspensions, suspensions, syrups, lotions, powders, suppositories, ovules, creams, ointments, gels, emulgels, ear, eye and nose drops, solutions, mouth rinse and gargles. The Company also produces veterinary products including vials, powders, oral liquids and fodder additives such as multivitamins and multi-minerals. It also manufactures detergents and cosmetics under license from French companies. The Company operates three production facilities include Factory for General Production, Penicillin Factory and Cephalosporin Factory.
Employees
-